Published 5 days ago • loading... • Updated 5 days ago

CRISPR’s cardio catch-all drives a biotech’s broad potential

Summary by PharmaVOICE

Scribe Therapeutics hopes to prevent cardiometabolic diseases by targeting underlying causes with CRISPR technology.

1 Articles

All

Left

Center

Right

Scribe Therapeutics hopes to prevent cardiometabolic diseases by targeting underlying causes with CRISPR technology.

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated5 days agoBias Distribution

100% Center

100% Center

Factuality

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

PharmaVOICE broke the news in 5 days ago on Tuesday, February 18, 2025.

Sources are mostly out of (0)